BiotechTube

Polyethylene glycol 4000 + Polyethylene glycol 4000 with electrolytes

ApprovedCompleted
0 watching 0 views this week🔥 Hot
82
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Constipation

Conditions

Constipation

Trial Timeline

Jan 1, 2008 → Jul 1, 2008

NCT ID
NCT00603681

About Polyethylene glycol 4000 + Polyethylene glycol 4000 with electrolytes

Polyethylene glycol 4000 + Polyethylene glycol 4000 with electrolytes is a approved stage product being developed by Orion Corporation for Constipation. The current trial status is completed. This product is registered under clinical trial identifier NCT00603681. Target conditions include Constipation.

Hype Score Breakdown

Clinical
30
Activity
20
Company
7
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00603681ApprovedCompleted

Competing Products

20 competing products in Constipation

See all competitors
ProductCompanyStageHype Score
YH12852 IR 0.05mg + YH12852 IR 0.1mg + YH12852 IR 0.3mg + YH12852 IR 0.5mg + YH12852 IR 1mg + YH12852 IR 2mg + YH12852 IR 3mg + YH12852 DR1 0.5mg + YH12852 DR1 1mg + YH12852 DR1 2mg + YH12852 DR1 4mg + YH12852 DR2 8mg + Prucalopride 2mg + PlaceboYuhanPhase 1/2
41
linaclotide + placeboAstellas PharmaPhase 2
52
linaclotide + PlaceboAstellas PharmaPhase 3
77
ASP0456 + PlaceboAstellas PharmaPhase 2
52
linaclotide + PlaceboAstellas PharmaPhase 3
77
linaclotideAstellas PharmaPre-clinical
23
Naldemedine + PlaceboShionogiPhase 3
77
Naldemedine + PlaceboShionogiApproved
85
NaldemedineShionogiPhase 1/2
41
Naldemedine + PlaceboShionogiPhase 3
77
Placebo + NaldemedineShionogiPhase 2
52
Naldemedine + PlaceboShionogiPhase 3
77
AJG555EisaiPhase 3
77
NaloxegolKyowa KirinPre-clinical
23
NaloxegolKyowa KirinPhase 1
33
naloxegol + non-PAMORA laxativeKyowa KirinPre-clinical
23
NaloxegolKyowa KirinPre-clinical
23
NaloxegolKyowa KirinPre-clinical
23
Prucalopride + PlaceboJohnson & JohnsonPhase 3
77
Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers) + Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)AbbViePhase 3
77

Other Products from Orion Corporation

Hydroxychloroquine + PlaceboApproved
82
Levosimendan + PlaceboApproved
82
MethotrexateApproved
82
DexmedetomidineApproved
82
Levosimendan + PlaceboApproved
82